Sarah Cappuyns
@CappuynsSarah
MD PhD researcher in digestive oncology @UZLeuven and @Onco_KULeuven. FWO PhD fellow strategic basic research. Visiting researcher @MountSinaiLiver and @IDIBAPS
🚨🔔🆕 Systemic management of advanced HCC: an increasingly complex game Full text here 👉: sciencedirect.com/science/articl… @DrAngelaLamarca @LorenzaRimassa @DJPinato
❗️Pathological response predicts RFS after neoadjuvant IO in #HCC❗️ ❓Can we translate this to preTx biomarkers in advanced HCC somehow❓#holygrail 👉 A rich source of data for translation research.. curious to see more in the future 👏 @A_DAlessioMD @DJPinato @ILCAnews
Have you finally found a predictive biomarker, in #HCC 🔥 @A_DAlessioMD ? 🔬 @ILCAnews @ImperialSandC #ILCA24 @myESMO @ASCO thelancet.com/journals/lanon…
Congratz!! Well-deserved 💪💪
I am honoured to receive the prestigious Young Investigator Award by @ILCAnews ! So grateful to my extraordinary mentors for having always supported me 🩺 @LorenzaRimassa @DJPinato Stay tuned for my presentation on pathological response in HCC tomorrow at #ILCA24 💊
Great to see so many young colleagues at #ILCA2024 in Toronto! Also, join us for the Young ILCA session on Science and Social Media later this afternoon. I promise it will be worth your while ! @ILCAnews @ArndtVogel @DrAngelaLamarca @DJPinato @ebtapper @LorenzaRimassa
What a start for #ILCA24 ! Enthusiastic participation to the roundtables organised by the Young ILCA committee - so enlightening to hear the career development advice of our stellar speakers! @marinabaretti @graokane @chiarabraconi @Valeriechew29 @ILCAnews
Join us in Hong Kong!! 👇👇
The ILCA Annual Conference call for abstracts is now open! 💙🧡 Join #ILCA25 in Hong Kong (Nov 19-21, 2025) to share your research, clinical experiences, & treatment advancements in #livercancer. ➡️ Submit here: eu.eventscloud.com/eSites/2002866…
I recently had a chat with @JDekervel about one of our favourite topics… Biomarkers in HCC: why we need them, and why they are so difficult to identify.. Have a listen!! 🎧 🎙️👇
🎙️ New podcast episode: Biomarkers in #HCC 🔬 Join Sarah Cappuyns (Y-ILCA) and Jeroen Dekervel (Digestive Oncologist, Leuven) as they dive into the role of biomarkers in #HCC treatment. 🎧 Listen now: open.spotify.com/episode/4bc3OD…
Immunosensitivity cuts across mismatch repair status in colorectal cancer Our preview article on the recent Acha-Sagredo et al. has been published today in @Cancer_Cell. shorturl.at/uJ8av
Today is a good day! Our new paper on a Belgian cohort of 283 high grade neuroendocrine neoplasms receives @OncoThor's stamp of approval. More on NET G3 vs NEC, functional imaging,... through erc.bioscientifica.com/view/journals/… @enetwerkbe @WLybaert
Functional imaging in NECs and much more... Check out this excellent paper. Lots of goodies in here such as >90% of NECs and G3 NETs FDG PET pos. Also, 66% of NECs pos on SSTR PET. What does that mean? The SSTR is not (yet) a good NEC target. @WLybaert erc.bioscientifica.com/view/journals/…
Was great contributing even just a little bit to this effort!! Congratulations to all !
Very excited to share our latest publication on the role of NOTCH1 in sexual dimorphism in liver cancer and published in @CD_AACR! Super proud of @KatieLindblad1 for leading this study as part of her outstanding PhD work.
❗️Save the Date: ILCA 2025 Annual Conference 📅 Nov. 19–21, 2025 📍 Hong Kong ➡️ilcalive.org/annual-confere… In 2025, we’re bringing the ILCA Annual Conference back to Asia! Join liver cancer specialists, researchers, and health professionals worldwide.🌏Stay tuned!
Resin-based Yttrium-90 Radioembolization as a Bridging or Downstaging ... sciencedirect.com/science/articl…
🔥off the press: Characterization of Tumor Responses in HCC Treated with Lenvatinib in REFLECT Liver Cancer doi.org/10.1159/000540… 👉ORR of 18.8% by RECIST v1.1 & 40.6% by mRECIST w/ Lenvatinib 🧐Response matters in HCC (even more today) @myESMO @EASLedu @ILCAnews #livertwitter
REVIEW @NatRevImmunol @faezzah23 Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumor microenvironment nature.com/articles/s4157…
👇👇👇
👍Great to catch up & discus social media with Y-ILCA colleagues & friends 👉Despite all, Twitter remains a valuable platform for engaging in science & medicine 😅Let’s stay in contact & interact @ilca #livertwitter @EASLedu
It's important to #communicate and #tweet about our #research and #science these days! Sharing session on how to do this effectively is both unique and fun! #yilca #ilca24 @ArndtVogel @A_DAlessioMD @LorenzaRimassa @CappuynsSarah @DrAngelaLamarca @ILCAnews
What is a good tweet? @ArndtVogel shared his views with the Y-ILCA community at #ILCA24🎙️ @ILCAnews @CappuynsSarah @angelopirozzi3 @LorenzaRimassa @DrAngelaLamarca @Valeriechew29
Thank you to everyone who joined us !! Now let’s go for drinks !
How to talk about science on social media? Our #ILCA2024 session just covered it! @ArndtVogel and our Y-ILCA shared tips on using social media to boost #livercancer research visibility. Want to level up your #science#communication? Share your thoughts or ask questions below!👇
Fantastic roundtable discussions with the experts & Young Investigators! #ILCA2024 @Valeriechew29 @siadaniela @chiarabraconi @graokane @ILCAnews. Look forward to the YI masterclass today on social media & science 🧬👩💻@CappuynsSarah @A_DAlessioMD
What a start for #ILCA24 ! Enthusiastic participation to the roundtables organised by the Young ILCA committee - so enlightening to hear the career development advice of our stellar speakers! @marinabaretti @graokane @chiarabraconi @Valeriechew29 @ILCAnews
As we approach #ILCA24, we want to know - do you use X/Twitter to discuss #livercancer research? 🧑🔬 Share your thoughts and join us on 17-19 Oct. in Toronto for an engaging session on maximizing the impact of your research on social media. Register now: shorturl.at/pn8V4